Publications Hosein AN, Wu M, Arcand SL, Lavallée S, Hébert J, Tonin PN, Basik M. Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. Cancer Res. 2010 Jul 15;70(14):5770-7. Epub 2010 Jun 22. PubMed Hamel S, Bouchard A, Ferrario C, Hassan S, Aguilar-Mahecha A, Buchanan M, Quenneville L, Miller W, Basik M. Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers. Breast Cancer Res Treat. 2010 Feb;120(1):47-57. Epub 2009 Mar 20.
Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A, Salvucci O, Basik M. The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer. Am J Pathol. 2009 Jul;175(1):66-73. Epub 2009 Jun 4. PubMed PMID: 19497995; PubMed Central PMCID: PMC2708795.
Aguilar-Mahecha A, Cantin C, O'Connor-McCourt M, Nantel A, Basik M. Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker. Proteome Sci. 2009 Apr 6;7:15. PubMed PMID: 19348683; PubMed Central PMCID: PMC2672067.
Hassan S, Ferrario C, Mamo A, Basik M. Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol. 2008 Feb;19(1):19-25. Epub 2007 Dec 3. Review. PubMed PMID: 18053705.
Hassan S, Baccarelli A, Salvucci O, Basik M. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res. 2008 Jan 15;14(2):446-54. PubMed PMID: 18223219.
Armour CM, McGowan-Jordan J, Lawrence SE, Bouchard A, Basik M, Allanson JE. A patient with de-novo partial deletion of Xp (p11.4-pter) and partial duplication of 22q (q11.2-qter). Clin Dysmorphol. 2008 Jan;17(1):23-6. PubMed PMID: 18049076.
Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA 3rd, Poplin EA, Hidalgo M, Baselga J, Clark EA, Mauro DJ. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol. 2007 Aug 1;25(22):3230-7. PubMed PMID: 17664471.
Aguilar-Mahecha A, Hassan S, Ferrario C, Basik M. Microarrays as validation strategies in clinical samples: tissue and protein microarrays. OMICS. 2006 Fall;10(3):311-26. Review. PubMed PMID: 17069510.
Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi
R, Basik M. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat. 2006 Jun;97(3):275-83. Epub 2005 Dec 13. PubMed PMID: 16344916.
Cancers Héréditaires: sein et côlon. Led workshop seminar at the Annual Congress of the Association Québécoise de Chirurgie. La Malbaie, Qc, May 31, 2007. Breast cancer update: prevention, detection and treatment.>Presented at the Annual Refresher Course for Family Physicians, McGill University Faculty of Medicine, Hotel Bonaventure Hilton, November 28th 2006. Workshop on genetic testing and counseling in breast cancer. Presented at the Annual Refresher Course for Family Physicians, McGill University Faculty of Medicine, Hotel Bonaventure Hilton, November 28th 2006. Discovering and validating novel targets and markers in breast and colon cancer. Seminar, Dept Anatomy and Cell Biology, McGill University. October 25, 2006 |